A detailed history of Geode Capital Management, LLC transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Geode Capital Management, LLC holds 21,744 shares of HCM stock, worth $377,693. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,744
Previous 21,744 -0.0%
Holding current value
$377,693
Previous $372,000 14.25%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$16.36 - $21.78 $9,177 - $12,218
-561 Reduced 2.52%
21,744 $372,000
Q3 2023

Nov 13, 2023

SELL
$11.85 - $16.95 $59,439 - $85,021
-5,016 Reduced 18.36%
22,305 $377,000
Q2 2023

Aug 11, 2023

BUY
$10.78 - $17.73 $48,639 - $79,997
4,512 Added 19.78%
27,321 $327,000
Q1 2023

May 15, 2023

SELL
$13.02 - $19.87 $595,508 - $908,814
-45,738 Reduced 66.73%
22,809 $296,000
Q4 2022

Feb 13, 2023

SELL
$7.65 - $15.51 $2.71 Million - $5.49 Million
-354,222 Reduced 83.79%
68,547 $1.01 Million
Q3 2022

Nov 14, 2022

BUY
$8.63 - $15.52 $219,063 - $393,959
25,384 Added 6.39%
422,769 $3.74 Million
Q2 2022

Aug 12, 2022

SELL
$8.59 - $20.77 $368,012 - $889,828
-42,842 Reduced 9.73%
397,385 $5 Million
Q1 2022

May 13, 2022

BUY
$15.52 - $35.65 $399,515 - $917,702
25,742 Added 6.21%
440,227 $8.28 Million
Q4 2021

Feb 11, 2022

BUY
$28.89 - $35.33 $1.96 Million - $2.4 Million
67,982 Added 19.62%
414,485 $14.4 Million
Q3 2021

Nov 12, 2021

BUY
$35.66 - $42.94 $1.39 Million - $1.68 Million
39,025 Added 12.69%
346,503 $12.6 Million
Q2 2021

Aug 13, 2021

BUY
$23.7 - $39.27 $932,310 - $1.54 Million
39,338 Added 14.67%
307,478 $12 Million
Q1 2021

May 12, 2021

BUY
$27.01 - $36.8 $1.06 Million - $1.44 Million
39,188 Added 17.12%
268,140 $7.52 Million
Q4 2020

Feb 12, 2021

BUY
$27.51 - $34.36 $202,170 - $252,511
7,349 Added 3.32%
228,952 $7.27 Million
Q3 2020

Nov 13, 2020

BUY
$25.8 - $34.61 $302,427 - $405,698
11,722 Added 5.59%
221,603 $7.11 Million
Q2 2020

Aug 13, 2020

BUY
$17.65 - $28.05 $465,253 - $739,398
26,360 Added 14.36%
209,881 $5.76 Million
Q1 2020

May 14, 2020

BUY
$15.19 - $29.51 $390,610 - $758,849
25,715 Added 16.3%
183,521 $3.26 Million
Q4 2019

Feb 13, 2020

BUY
$17.17 - $25.95 $90,897 - $137,379
5,294 Added 3.47%
157,806 $3.93 Million
Q3 2019

Nov 12, 2019

BUY
$17.84 - $22.69 $437,008 - $555,814
24,496 Added 19.14%
152,512 $2.71 Million
Q2 2019

Aug 14, 2019

BUY
$22.0 - $31.78 $140,184 - $202,502
6,372 Added 5.24%
128,016 $2.8 Million
Q1 2019

May 14, 2019

BUY
$21.27 - $30.58 $142,721 - $205,191
6,710 Added 5.84%
121,644 $3.7 Million
Q4 2018

Feb 13, 2019

BUY
$23.09 - $37.69 $2.29 Million - $3.75 Million
99,388 Added 639.32%
114,934 $2.64 Million
Q3 2018

Nov 13, 2018

BUY
$26.55 - $34.38 $35,842 - $46,413
1,350 Added 9.51%
15,546 $500,000
Q2 2018

Aug 14, 2018

BUY
$27.79 - $34.49 $394,506 - $489,620
14,196 New
14,196 $427,000
Q1 2018

May 15, 2018

SELL
$28.87 - $41.13 $189,213 - $269,566
-6,554 Closed
0 $0
Q4 2017

Feb 13, 2018

BUY
$27.41 - $39.42 $179,645 - $258,358
6,554
6,554 $258,000

Others Institutions Holding HCM

About HUTCHMED (China) Ltd


  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $3B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.